Breast cancer subtypes defined by their estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2) status likely arise via different carcinogenic mechanisms. This evidence concerns the gene ERBB2 and breast cancer.